Brief: Beyond Air Announces Positive Data For Inhaled Nitric Oxide To Treat Covid-19 With Lungfit Pro
24/10/2022 12:38
Oct 24 (Reuters) - Beyond Air Inc XAIR.O :
* BEYOND AIR® ANNOUNCES POSITIVE DATA FOR INHALED NITRIC
OXIDE
(NO) TO TREAT COVID-19 WITH LUNGFIT® PRO IN A POSTER
PRESENTATION AT IDWEEK 2022
* BEYOND AIR - LUNGFIT PRO STUDY ANALYSIS IN VCAP PATIENTS
SHOWS
IMPROVED EFFICACY ON MULTIPLE PARAMETERS IN INO TREATMENT GROUP
VERSUS STANDARD SUPPORTIVE TREATMENT
Source text for Eikon: ID:nGNX9LHrxv
Further company coverage: XAIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beyond Air
See all newsBrief: Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments
Beyond Air Inc reports results for the quarter ended June 30 - Earnings Summary
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Beyond Air Inc expected to post a loss of $10.80 a share - Earnings Preview
NASDAQ RESUMED AT 04:00 AM